SCHEMBL24211507

SCHEMBL24211507

C=C(C)C(=O)OCCCCSc1ncc(-c2ccc(C)cc2C)c(=O)n1C

nearest known ligand 0.35

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HTT P42858 3/20 0.35
POLB P06746 1/20 0.35
APEX1 P27695 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.33
ALDH1A1 P00352 2/20 0.33
RXFP1 Q9HBX9 1/20 0.33
KDM4E B2RXH2 1/20 0.33
MAPT P10636 6/20 0.32
LMNA P02545 3/20 0.32
TSHR P16473 2/20 0.32
PDPK1 O15530 1/20 0.32
TP53 P04637 1/20 0.32
GAA P10253 1/20 0.31
HPGD P15428 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
DAO P14920 1/20 0.31
HRH3 Q9Y5N1 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24211503 0.89 HTT (0.36) HTTPOLBAPEX1TDP1SMN1; SMN2
SCHEMBL26063840 0.85 HRH3 (0.33) HTTSMN1; SMN2ALDH1A1RXFP1KDM4E
SCHEMBL24211704 0.83 POLB (0.41) HTTPOLBAPEX1TDP1SMN1; SMN2
SCHEMBL26063049 0.83 POLB (0.41) HTTPOLBAPEX1TDP1SMN1; SMN2
SCHEMBL24211565 0.83 POLB (0.41) HTTPOLBAPEX1TDP1SMN1; SMN2
SCHEMBL24211504 0.83 HTT (0.40) HTTPOLBAPEX1TDP1SMN1; SMN2
SCHEMBL24211543 0.82 HTT (0.42) HTTPOLBAPEX1TDP1SMN1; SMN2
SCHEMBL24211502 0.82 HDAC2 (0.41) HTTPOLBAPEX1TDP1SMN1; SMN2
SCHEMBL24211549 0.82 HTT (0.42) HTTPOLBAPEX1TDP1SMN1; SMN2
SCHEMBL26063065 0.80 HSD11B1 (0.35) HTTPOLBAPEX1TDP1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4182737-B1 OPTICALLY ACTIVE DEVICES AMO Ireland (IE) 2024-07-03 EP disclosed
US-20230273456-A1 OPTICALLY ACTIVE DEVICES JOHNSON & JOHNSON SURGICAL VISION INC (US) 2023-08-31 US disclosed
US-20230273456-A1 OPTICALLY ACTIVE DEVICES JOHNSON & JOHNSON SURGICAL VISION INC (US) 2023-08-31 US disclosed
WO-2022012799-A1 OPTICALLY ACTIVE DEVICES MERCK PATENT GMBH (DE) 2022-01-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230273456-A1 OPTICALLY ACTIVE DEVICES PDE6C, PDE6D, PDE6A HTT 1290/4885POLB 1579/4885APEX1 147/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.